177 related articles for article (PubMed ID: 15833860)
1. Cortactin overexpression inhibits ligand-induced down-regulation of the epidermal growth factor receptor.
Timpson P; Lynch DK; Schramek D; Walker F; Daly RJ
Cancer Res; 2005 Apr; 65(8):3273-80. PubMed ID: 15833860
[TBL] [Abstract][Full Text] [Related]
2. Aberrant expression of cortactin in head and neck squamous cell carcinoma cells is associated with enhanced cell proliferation and resistance to the epidermal growth factor receptor inhibitor gefitinib.
Timpson P; Wilson AS; Lehrbach GM; Sutherland RL; Musgrove EA; Daly RJ
Cancer Res; 2007 Oct; 67(19):9304-14. PubMed ID: 17909038
[TBL] [Abstract][Full Text] [Related]
3. Src promotes destruction of c-Cbl: implications for oncogenic synergy between Src and growth factor receptors.
Bao J; Gur G; Yarden Y
Proc Natl Acad Sci U S A; 2003 Mar; 100(5):2438-43. PubMed ID: 12604776
[TBL] [Abstract][Full Text] [Related]
4. Cbl and Itch binding sites in ERBB4 CYT-1 and CYT-2 mediate K48- and K63-polyubiquitination, respectively.
Meijer IM; van Rotterdam W; van Zoelen EJ; van Leeuwen JE
Cell Signal; 2013 Feb; 25(2):470-8. PubMed ID: 23153581
[TBL] [Abstract][Full Text] [Related]
5. Epidermal growth factor receptors with tyrosine kinase domain mutations exhibit reduced Cbl association, poor ubiquitylation, and down-regulation but are efficiently internalized.
Padrón D; Sato M; Shay JW; Gazdar AF; Minna JD; Roth MG
Cancer Res; 2007 Aug; 67(16):7695-702. PubMed ID: 17699773
[TBL] [Abstract][Full Text] [Related]
6. Serine mutations that abrogate ligand-induced ubiquitination and internalization of the EGF receptor do not affect c-Cbl association with the receptor.
Oksvold MP; Thien CB; Widerberg J; Chantry A; Huitfeldt HS; Langdon WY
Oncogene; 2003 Nov; 22(52):8509-18. PubMed ID: 14627991
[TBL] [Abstract][Full Text] [Related]
7. Cbl-mediated ubiquitinylation is required for lysosomal sorting of epidermal growth factor receptor but is dispensable for endocytosis.
Duan L; Miura Y; Dimri M; Majumder B; Dodge IL; Reddi AL; Ghosh A; Fernandes N; Zhou P; Mullane-Robinson K; Rao N; Donoghue S; Rogers RA; Bowtell D; Naramura M; Gu H; Band V; Band H
J Biol Chem; 2003 Aug; 278(31):28950-60. PubMed ID: 12754251
[TBL] [Abstract][Full Text] [Related]
8. Cortactin overexpression regulates actin-related protein 2/3 complex activity, motility, and invasion in carcinomas with chromosome 11q13 amplification.
Rothschild BL; Shim AH; Ammer AG; Kelley LC; Irby KB; Head JA; Chen L; Varella-Garcia M; Sacks PG; Frederick B; Raben D; Weed SA
Cancer Res; 2006 Aug; 66(16):8017-25. PubMed ID: 16912177
[TBL] [Abstract][Full Text] [Related]
9. A mutant EGF-receptor defective in ubiquitylation and endocytosis unveils a role for Grb2 in negative signaling.
Waterman H; Katz M; Rubin C; Shtiegman K; Lavi S; Elson A; Jovin T; Yarden Y
EMBO J; 2002 Feb; 21(3):303-13. PubMed ID: 11823423
[TBL] [Abstract][Full Text] [Related]
10. Herpes simplex virus 1 infected cell protein 0 forms a complex with CIN85 and Cbl and mediates the degradation of EGF receptor from cell surfaces.
Liang Y; Kurakin A; Roizman B
Proc Natl Acad Sci U S A; 2005 Apr; 102(16):5838-43. PubMed ID: 15824310
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of cortactin in head and neck squamous cell carcinomas can be uncoupled from augmented EGF receptor expression.
Fantozzi I; Grall D; Cagnol S; Stanchi F; Sudaka A; Brunstein MC; Bozec A; Fischel JL; Milano G; Van Obberghen-Schilling E
Acta Oncol; 2008; 47(8):1502-12. PubMed ID: 18607838
[TBL] [Abstract][Full Text] [Related]
12. Association with HSP90 inhibits Cbl-mediated down-regulation of mutant epidermal growth factor receptors.
Yang S; Qu S; Perez-Tores M; Sawai A; Rosen N; Solit DB; Arteaga CL
Cancer Res; 2006 Jul; 66(14):6990-7. PubMed ID: 16849543
[TBL] [Abstract][Full Text] [Related]
13. LRIG1 restricts growth factor signaling by enhancing receptor ubiquitylation and degradation.
Gur G; Rubin C; Katz M; Amit I; Citri A; Nilsson J; Amariglio N; Henriksson R; Rechavi G; Hedman H; Wides R; Yarden Y
EMBO J; 2004 Aug; 23(16):3270-81. PubMed ID: 15282549
[TBL] [Abstract][Full Text] [Related]
14. TULA: an SH3- and UBA-containing protein that binds to c-Cbl and ubiquitin.
Feshchenko EA; Smirnova EV; Swaminathan G; Teckchandani AM; Agrawal R; Band H; Zhang X; Annan RS; Carr SA; Tsygankov AY
Oncogene; 2004 Jun; 23(27):4690-706. PubMed ID: 15107835
[TBL] [Abstract][Full Text] [Related]
15. Direct interaction of Cbl with pTyr 1045 of the EGF receptor (EGFR) is required to sort the EGFR to lysosomes for degradation.
Grøvdal LM; Stang E; Sorkin A; Madshus IH
Exp Cell Res; 2004 Nov; 300(2):388-95. PubMed ID: 15475003
[TBL] [Abstract][Full Text] [Related]
16. Cortactin is a substrate of activated Cdc42-associated kinase 1 (ACK1) during ligand-induced epidermal growth factor receptor downregulation.
Kelley LC; Weed SA
PLoS One; 2012; 7(8):e44363. PubMed ID: 22952966
[TBL] [Abstract][Full Text] [Related]
17. Resistance to small molecule inhibitors of epidermal growth factor receptor in malignant gliomas.
Li B; Chang CM; Yuan M; McKenna WG; Shu HK
Cancer Res; 2003 Nov; 63(21):7443-50. PubMed ID: 14612544
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of epidermal growth factor receptor induces sequestration of extracellular signal-related kinases and selective attenuation of specific epidermal growth factor-mediated signal transduction pathways.
Habib AA; Chun SJ; Neel BG; Vartanian T
Mol Cancer Res; 2003 Jan; 1(3):219-33. PubMed ID: 12556561
[TBL] [Abstract][Full Text] [Related]
19. Differential roles of ERK and Akt pathways in regulation of EGFR-mediated signaling and motility in prostate cancer cells.
Gan Y; Shi C; Inge L; Hibner M; Balducci J; Huang Y
Oncogene; 2010 Sep; 29(35):4947-58. PubMed ID: 20562913
[TBL] [Abstract][Full Text] [Related]
20. Intersectin regulates epidermal growth factor receptor endocytosis, ubiquitylation, and signaling.
Martin NP; Mohney RP; Dunn S; Das M; Scappini E; O'Bryan JP
Mol Pharmacol; 2006 Nov; 70(5):1643-53. PubMed ID: 16914641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]